NetworkNewsBreaks

FridayOct 25, 2024 2:58 pm

NetworkNewsBreaks – Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF) Eyes Prospective Horizon at Storm Copper Project

Aston Bay (TSX.V: BAY) (OTCQB: ATBHF) recently released an update regarding its Storm Copper Project’s 2024 drilling exploration program. The program focused on expansion at the Cyclone and Chinook Prospects and delineation drilling at the Lightning Ridge discovery and Thunder Prospect. “The first deep drill hole of the year adds another success to the 2024 exploration program at Storm,” said Aston Bay CEO Thomas Ullrich. “The style of copper mineralization intercepted and its stratigraphic location is similar to Cyclone — this may be the fault-offset southern portion of the deposit and could add to a potential future resource. “In addition…

Continue Reading

FridayOct 25, 2024 1:40 pm

NetworkNewsBreaks – GolfLync’s Traction, Market Fit and Experienced Executive Team Underscore Its Investment Opportunity

GolfLync, the company behind the GolfLync app – a social network for matching golf games and players, is currently in a stage reminiscent of Flip: a promising startup with a unique value proposition. A recent article reads, “Originally launched with the goal of creating a community-driven platform for golfers, GolfLync combines social networking with features tailored to the sport, such as event coordination, performance tracking and golf-related content sharing… The app’s market fit, proven user acquisition, traction and experienced executive team make it an investment worth looking at closely. In addition, GolfLync is now building on its initial success and…

Continue Reading

FridayOct 25, 2024 12:44 pm

NetworkNewsBreaks – Upstream Spotlights Streamlined KYC Identity Verification Process

Upstream, a MERJ Exchange market and trading app, published a blog today that discussed details on completing its streamlined KYC identity verification. The blog reads, “Upstream traders are prompted to complete our light-touch KYC (Know Your Customer) identity verification process when your Upstream account balance reaches $500 or more, or when you’re withdrawing funds. Like the rest of our stock trading app experience, KYC identity verification was also designed to be as fast and frictionless as possible… Protecting your financial well-being is our top priority at Upstream... As a fully regulated marketplace, verifying that you are who you say you…

Continue Reading

FridayOct 25, 2024 12:26 pm

NetworkNewsBreaks – Meta Platforms Inc. (NASDAQ: META) Leads in AI Innovation

Meta (NASDAQ: META) is a leading technology company known for its social media platforms, including Facebook, Instagram and WhatsApp. Recently, Meta has made significant strides in artificial intelligence by launching compressed AI models that operate directly on smartphones. This innovation allows AI to work faster and more privately, using less memory than cloud-based solutions. This positions Meta ahead of competitors like Google and Apple in integrating advanced AI into mobile devices. The impact of Meta’s advancements is reflected in its stock performance. The current stock price of META is $579.23, marking an increase of 2.02% or $11.45. This rise indicates…

Continue Reading

FridayOct 25, 2024 10:40 am

NetworkNewsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Groundbreaking Cancer Treatment on RedChip’s Bloomberg TV Program

Calidi Biotherapeutics (NYSE American: CLDI), a leader in oncolytic virotherapy (OV) for cancer, will feature in a RedChip Small Stocks, Big Money™ interview on Bloomberg TV on Oct. 26 at 7 p.m. ET. During the interview, Calidi’s Chief Business Officer, Stephen Thesing, provides an update on Calidi’s innovative approach, which uses engineered viruses to target and eliminate cancer cells. Calidi’s proprietary cell-based technology enhances the potency and longevity of these viruses by protecting them from immune response, boosting treatment efficacy. With IV-based and direct tumor administration methods, Calidi is advancing a new frontier in cancer treatment within the multi-billion-dollar oncology…

Continue Reading

ThursdayOct 24, 2024 3:23 pm

NetworkNewsBreaks – SuperCom Ltd. (NASDAQ: SPCB) Is at the Forefront of the EM Sector with Cutting-Edge Technology

SuperCom (NASDAQ: SPCB) is leveraging its electronic monitoring (“EM”) platform as a cutting-edge solution that is ahead of the curve in what is still a niche market. Its client list in Europe and the United States is continuing to grow. EM technology is becoming increasingly popular among European governments to advance the social inclusion of criminal offenders through probationary services, reducing recidivism. The company recently announced $2.6 million in new orders from European governments. “We are delighted to continue strengthening our collaboration with European governments,” said SuperCom President and CEO Ordan Trabelsi. “It highlights our leadership in the electronic monitoring…

Continue Reading

ThursdayOct 24, 2024 1:00 pm

NetworkNewsBreaks – Clene Inc. (NASDAQ: CLNN) Set to Discuss Lead Candidate Biomarker with FDA Leadership

Clene (NASDAQ: CLNN) and its wholly owned subsidiary Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (“ALS”) and multiple sclerosis (“MS”), recently announced an upcoming meeting with U.S. Food and Drug Administration (“FDA”) leadership. The focus is to discuss Clene’s CNM-Au8® biomarker and related clinical and survival data for ALS. “FDA’s Director of the Office on New Drugs, the Director of the Office of Neuroscience, and the Division of Neurology 1 (‘DN1’) review team, as well as recognized key opinion leaders in ALS,…

Continue Reading

ThursdayOct 24, 2024 12:45 pm

NetworkNewsBreaks – CBD Life Sciences Inc. (CBDL) Poised to Become Game Changer in the Hemp Industry

CBD Life Sciences (OTC: CBDL) today announced its potential for explosive profits in a $70 billion industry and, with its innovative product line and strategic market positioning, standing ready to deliver unparalleled returns for shareholders. “The U.S. is on the verge of a historic shift. With the Biden administration, led by Vice President Kamala Harris, taking bold steps toward federal marijuana legalization, the opportunities for companies in the cannabis and CBD sectors are poised to skyrocket,” the announcement reads. “According to industry projections, the legal cannabis market in the U.S. is expected to surpass $70 billion by 2028, driven by…

Continue Reading

ThursdayOct 24, 2024 11:45 am

NetworkNewsBreaks – Trump Media & Technology Group Corp. (NASDAQ: DJT) Launches Truth+ on Android TV

Trump Media & Technology Group (NASDAQ: DJT) has launched its Truth+ streaming app for Android TV. This app offers diverse content, including news, entertainment and children’s programming, available through linear TV and Video on Demand (“VOD”). It enhances the Truth Social platform with features like live TV rewind and a Spanish language interface. CEO Devin Nunes emphasizes the importance of expanding to Android TV, complementing the existing Apple TV platform. This move aims to strengthen Truth Social as a hub for news and entertainment. DJT plans to extend Truth+ to other platforms like Samsung, LG, Amazon Fire, and Roku, enhancing…

Continue Reading

ThursdayOct 24, 2024 11:30 am

NetworkNewsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) to Present Antitumor Virotherapy Platform Data at Three Scientific Conferences

Calidi Biotherapeutics (NYSE American: CLDI), a clinical-stage biotechnology company, is set to present data on its innovative systemic antitumor virotherapy platform, RTNova (CLD-400), at multiple scientific conferences. These include the International Oncolytic Virotherapy Conference in Rotterdam (Oct. 27-30), the Immuno US 2024 in San Diego (Oct. 28-29), and the Society for Immunotherapy of Cancer Annual Meeting in Houston (November 6-10). RTNova is designed to address the challenges posed by untargetable and untreatable metastatic diseases by targeting multiple tumor sites and altering the tumor immune microenvironment. This approach not only facilitates easier administration but also broadens the potential patient population who…

Continue Reading